How the Treatment of Lung Cancer Has Been Transformed in the Era of Molecular Biomarker Testing

David L. Rimm, MD, PhD; Roy Herbst, MD, PhD

Video Categories: PMO Interview with the Innovator Series: Volume 12 and Video Library

Drs Roy Herbst and David Rimm review how biomarker testing has transformed the way patients with lung cancer are treated, and how both medical oncologists and pathologists contribute to these changes.

October 8, 2014

Approaching Unmet Clinical Needs in Polycythemia Vera

Dr. Michaelis discusses what approaches she takes for PV patients with unmet clinical needs such as recurrent thrombosis or hemorrhage. Supported through funding from Incyte

September 20, 2013

Personalized Medicine and the Affordable Care Act

Grant Lawless discusses the long term goal of personalized medicine as it relates to the Affordable Care Act